Migraine and Stroke Risk: What the Research Actually Shows

The relationship between migraine and stroke is one of the most clinically important and most frequently misunderstood aspects of migraine medicine. Research has established that migraine with aura is associated with a modestly elevated risk of ischemic stroke compared to the general population. This finding has generated significant concern among people with migraine and their families, and in some cases has led to unnecessary anxiety and avoidance of effective treatments. Understanding what the research actually shows — the magnitude of the risk, who is most affected, and what modifiable factors matter — provides a more accurate and useful framework than the simplified version that sometimes circulates.

What the Research Shows

Multiple large epidemiological studies and meta-analyses have documented an association between migraine with aura and ischemic stroke. A widely cited meta-analysis found that migraine with aura is associated with approximately a twofold increase in ischemic stroke risk compared to people without migraine. For migraine without aura, the evidence for elevated stroke risk is weaker and less consistent.

A twofold increase in relative risk sounds substantial, but the absolute risk must be contextualized. Ischemic stroke is relatively uncommon in the young and middle-aged population where migraine with aura is most prevalent. A twofold increase over a very low baseline risk translates to a small absolute increase in risk. For a healthy young woman without other stroke risk factors, the absolute annual stroke risk associated with migraine with aura remains low, though not negligible.

Who Is at Highest Risk

The stroke risk associated with migraine with aura is substantially amplified by the presence of additional risk factors. The combination of migraine with aura, combined oral contraceptive use, and smoking is associated with a dramatically elevated stroke risk — a finding that has influenced clinical guidance on contraceptive choice in women with migraine with aura.

Current guidelines from major headache and neurology organizations advise against the use of combined oral contraceptives containing estrogen in women with migraine with aura, particularly those who smoke or have other cardiovascular risk factors. Other stroke risk factors including hypertension, diabetes, elevated cholesterol, obesity, physical inactivity, and atrial fibrillation interact with migraine with aura to increase risk. Managing these modifiable risk factors is particularly important for people with migraine with aura.

The Mechanism Connecting Migraine With Aura to Stroke

The biological mechanisms connecting migraine with aura to stroke risk are not fully established but several hypotheses have been proposed. Cortical spreading depression, the electrophysiological event that produces migraine aura, produces transient changes in cerebrovascular function including oligemia, a reduction in cortical blood flow. Repeated episodes of cortical spreading depression may have cumulative effects on the cerebrovascular endothelium.

People with migraine with aura have higher rates of patent foramen ovale, a small opening between the right and left atria of the heart that normally closes after birth. Patent foramen ovale may allow small emboli that would otherwise be filtered by the pulmonary circulation to reach the brain directly. The relationship between patent foramen ovale, migraine with aura, and stroke has been extensively studied but causal relationships remain uncertain.

What People With Migraine With Aura Should Do

The elevated stroke risk associated with migraine with aura does not mean that people with this condition should avoid treatment or live in fear of stroke. It means that cardiovascular risk factors should be managed carefully, that contraceptive choices should be discussed with a healthcare provider in light of the migraine with aura diagnosis, that smoking should be strongly discouraged, and that any sudden severe headache that differs from the usual migraine pattern should be evaluated promptly.

People with migraine with aura who develop new neurological symptoms, particularly those with abrupt onset that differ from their usual aura pattern, should seek emergency evaluation promptly. The gradual development of aura over fifteen to thirty minutes and complete resolution within sixty minutes help distinguish migraine aura from transient ischemic attack, but uncertainty in a specific episode warrants medical evaluation.

Monitoring and Follow-Up

People with migraine with aura benefit from cardiovascular risk factor monitoring as part of their ongoing care. Blood pressure checks, lipid screening, and glucose monitoring at appropriate intervals allow early identification and management of modifiable risk factors that interact with migraine with aura to elevate stroke risk. These monitoring activities are part of standard preventive care and do not require specialist referral in most cases.